Lion Point Capital, LP
Lion Point Capital, LP reported 35 holdings worth US$20.9M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Lion Point Capital, LP reported 35 holdings worth US$20.9M as of Jun 30, 2026. Largest: Cue Biopharma, Inc., Praxis Precision Medicines, Inc. and Fennec Pharmaceuticals Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 35
- Value as reported
- US$20.9M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Cue Biopharma, Inc. | 52,928 | US$1.67M | 8.0% |
| Praxis Precision Medicines, Inc. | 4,450 | US$1.49M | 7.1% |
| Fennec Pharmaceuticals Inc. | 112K | US$1.21M | 5.8% |
| Milestone Pharmaceuticals Inc. | 820K | US$1.1M | 5.3% |
| Benitec Biopharma Inc. | 62,000 | US$830K | 4.0% |
| Syndax Pharmaceuticals, Inc. | 36,000 | US$787K | 3.8% |
| Biohaven Ltd. | 51,700 | US$769K | 3.7% |
| Geron Corporation | 578K | US$740K | 3.5% |
| Ardelyx, Inc. | 129K | US$656K | 3.1% |
| Lantheus Holdings, Inc. | 5,500 | US$610K | 2.9% |
| Disc Medicine, Inc. | 8,100 | US$592K | 2.8% |
| Sarepta Therapeutics, Inc. | 28,500 | US$512K | 2.4% |
| Humacyte, Inc. | 650K | US$507K | 2.4% |
| Kura Oncology, Inc. | 46,000 | US$505K | 2.4% |
| Viatris Inc. | 27,700 | US$440K | 2.1% |
| Dyne Therapeutics, Inc. | 18,000 | US$400K | 1.9% |
| Bridgebio Pharma, Inc. | 5,000 | US$372K | 1.8% |
| Edgewise Therapeutics, Inc. | 9,100 | US$370K | 1.8% |
| Pacira Biosciences, Inc. | 13,500 | US$342K | 1.6% |
| Regenxbio Inc. | 26,600 | US$319K | 1.5% |
| Rocket Pharmaceuticals, Inc. | 86,000 | US$294K | 1.4% |
| Janux Therapeutics, Inc. | 19,000 | US$292K | 1.4% |
| Mineralys Therapeutics, Inc. | 10,500 | US$283K | 1.4% |
| Seres Therapeutics, Inc. | 31,570 | US$249K | 1.2% |
| Azenta, Inc. | 9,700 | US$248K | 1.2% |
| Jasper Therapeutics, Inc. | 465K | US$196K | 0.94% |
| Innoviva, Inc. | 8,200 | US$186K | 0.89% |
| Innate Pharma Sa Class A | 81,151 | US$149K | 0.71% |
| Arcutis Biotherapeutics, Inc. | 5,250 | US$138K | 0.66% |
| Spruce Biosciences, Inc. | 1,000 | US$54,000 | 0.26% |
Source
View original at SEC
Related